US20070185570A1 - Material for aneurysm curing - Google Patents
Material for aneurysm curing Download PDFInfo
- Publication number
- US20070185570A1 US20070185570A1 US10/568,694 US56869404A US2007185570A1 US 20070185570 A1 US20070185570 A1 US 20070185570A1 US 56869404 A US56869404 A US 56869404A US 2007185570 A1 US2007185570 A1 US 2007185570A1
- Authority
- US
- United States
- Prior art keywords
- ion
- ions
- aneurysm
- irradiated
- eptfe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/18—Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
Definitions
- the present invention relates to a material for treating aneurysms, which can be used to treat aneurysms, and a production method thereof.
- subarachnoid hemorrhages caused by ruptured cerebral aneurysms occur to approximately 12 out of 100,000 people. More specifically, this malady occurs to approximately 15,000 people among a total population of 126,000,000 in Japan. Approximately 50% of such patients with subarachnoid hemorrhages die due to the first subarachnoid hemorrhage. Also, if a particular treatment is not given, 25% to 30% of such patients die due to rebleeding.
- the clipping of an aneurysm neck portion by craniotomy ( FIG. 1 a ), or a method of forming a thrombus in an aneurysm portion by an intravascular treatment using a detachable coil ( FIG. 1 b ) is adopted.
- Such methods are effective for a dome-shaped aneurysm, but in the treatment for a cerebral aneurysm having a risk of rupture called “wide neck aneurysm”, the clipping can not be carried out, and also the treatment using a coil can not be applied because the coil is moved to a peripheral portion due to the flowing of bloodstream.
- ePTFE fiber In order to prevent such a wide neck type aneurysm from rupture, the affected area is wrapped with ePTFE fiber, an ePTFE sheet or silk fiber, and thereafter a living tissue adhesive called a fibrin glue is used.
- fibrin glue a living tissue adhesive
- these materials are extremely poor in terms of affinity with a vascular wall and the adhesiveness of a fibrin glue. Thus, the materials often become detached, and it becomes impossible to prevent such rupture by strong wrapping in the actual situation. Accordingly, clinicians have desired a material for quickly and strongly wrapping such a wide neck type cerebral aneurysm, which is capable of preventing the rupture thereof.
- a polymer material modified by ion bombardment be used for various types of biomaterials.
- a cell-adhesive material which is composed of a polymer material containing carbon as a constitutional element and which is produced by modifying at least a portion of the surface thereof by ion bombardment
- a material for adhering to bone and/or fascia which is composed of a polymer material containing carbon as a constitutional element and which is produced by modifying at least a portion of the surface thereof by ion bombardment
- Ion beam-irradiated ePTFE has cellular adhesiveness.
- this material When this material is used as a wrapping material for preventing the rupture of an aneurysm, it exhibits affinity with the outer wall of the blood vessel and has a rupture-preventing effect.
- the above material when the rupture of an aneurysm occurs in the wrapping, the above material has a property of preventing the leakage of blood in the brain, because of its strong fixing ability.
- the above material has cellular adhesiveness, the self-repairing ability of the vascular wall is also improved.
- the preset invention has been completed based on these findings.
- the present invention provides a material for treating aneurysms, which is composed of a polymer material containing carbon as a constitutional element, and which is produced by modifying at least a portion of the surface thereof by ion bombardment.
- the polymer material containing carbon as a constitutional element is expanded polytetrafluoroethylene (ePTFE), polylactic acid, silicone, or silk.
- modification by ion bombardment is carried out by ion implantation using an ion beam with an acceleration energy that is between 1 keV and 2 MeV.
- modification by ion bombardment is carried out by ion implantation within a dose volume ⁇ such that 1 ⁇ 10 12 ⁇ 1 ⁇ 10 17 ions/cm 2 .
- the present invention provides a method for producing a material for treating aneurysms, which is characterized in that ions are implanted into at least a portion of the surface of a polymer material containing carbon as a constitutional element, within a dose volume ⁇ such that 1 ⁇ 10 12 ⁇ 1 ⁇ 10 17 ions/cm 2 .
- the polymer material containing carbon as a constitutional element is expanded polytetrafluoroethylene (ePTFE), polylactic acid, silicone, or silk.
- the present invention provides the use of a polymer material containing carbon as a constitutional material, at least a portion of the surface of which has been modified by ion bombardment, for the production of a material for treating aneurysms.
- the present invention provides a method for treating aneurysms, which comprises wrapping the aneurysm of a patient using a polymer material containing carbon as a constitutional material, at least a portion of the surface of which has been modified by ion bombardment.
- FIG. 1 shows the summary of a method for treating aneurysms.
- FIG. 1 a shows the clipping of an aneurysm neck portion;
- FIG. 1 b shows a therapeutic method involving the formation of a thrombus;
- FIG. 1 c shows wrapping (whereby the periphery of an aneurysm is wrapped with ePTFE).
- FIG. 2 shows the structural formula of ePTFE.
- FIG. 3 shows SEM images ( ⁇ 8,000) of: (a) unirradiated ePTFE; (b) 5 ⁇ 10 14 Ar + -irradiated sample; and (c) 1 ⁇ 10 14 Kr + -irradiated sample.
- FIG. 4 shows the FT-IR-ATR spectra of (a) unirradiated ePTFE; (b) 5 ⁇ 10 14 Ar + -irradiated sample; and (c) 1 ⁇ 10 14 Kr + -irradiated sample.
- FIG. 5 shows the Raman spectrum of ePTFE sample.
- FIG. 6 shows images of cultured cells observed with a phase contract microscope
- FIG. 7 shows the state of the sample of the present invention after a rabbit carotid artery has been wrapped with the above sample.
- FIG. 8 shows an aneurysm model produced in the carotid artery of a beagle dog.
- FIG. 9 shows the state of a wrapped aneurysm of a beagle dog.
- FIG. 10 shows a histological photograph of unirradiated ePTFE (3 months) used to wrap a rabbit carotid artery. (a) indicates 100-fold, and (b) indicates 400-fold.
- FIG. 11 shows a histological photograph of Ar + -irradiated ePTFE (1 week) used to wrap a rabbit carotid artery. (a) indicates 100-fold, and (b) indicates 400-fold.
- FIG. 12 shows a histological photograph of Kr + -irradiated material (1 week) used to wrap a rabbit carotid artery. (a) indicates 100-fold, and (b) indicates 400-fold.
- FIG. 13 shows a histological photograph of Ar + -irradiated ePTFE (1 month) used to wrap a rabbit carotid artery. (a) indicates 100-fold, and (b) indicates 400-fold.
- FIG. 14 shows a histological photograph of Kr + -irradiated material (1 month) used to wrap a rabbit carotid artery. (a) indicates 100-fold, and (b) indicates 400-fold.
- a therapeutic method of a wide neck type cerebral aneurysm only a method comprising wrapping the entire aneurysm with a polymer material and then adhering it with a blood-derived adhesive called a fibrin glue, so as to prevent the rupture of the aneurysm, has been applied.
- a material such as ePTFE or silk has been used.
- a material has poor cellular adhesiveness, and has no affinity with the outer wall of the blood vessel.
- the fixing ability of the fibrin glue is considerably weak in the actual situation.
- An ion beam-irradiated polymer material such as ePTFE has cellular adhesiveness, and also has affinity with the wrapped outer wall of the blood vessel. Even when the rupture of an aneurysm has occurred in the inside of the wrapping, since the above material has strong fixing ability, it is able to prevent the blood from leaking into the brain. Moreover, since the above material has cellular adhesiveness, the self-repairing ability of the vascular wall is also improved. Furthermore, as a result of in vitro experiments and animal experiments, it became clear that the adhesiveness of a fibrin glue is significantly improved by irradiation of ion beam. The use of this material enables a more complete treatment of an unruptured aneurysm.
- the present invention relates to a material for treating aneurysms, which is formed by irradiation of ion beam to a polymer material (for example, expanded polytetrafluoroethylene, polylactic acid, silicone, silk, etc.), so as to impart cellular adhesiveness thereto.
- a polymer material for example, expanded polytetrafluoroethylene, polylactic acid, silicone, silk, etc.
- the type of a polymer material containing carbon as a constitutional element used in the present invention is not particularly limited, as long as it is a material having biocompatibility and good handlability, and any given material can be used.
- Examples of a polymer material preferably used in the present invention may include expanded polytetrafluoroethylene (ePTFE), polylactic acid, silicone, and silk. Of these, expanded polytetrafluoroethylene (ePTFE) is particularly preferable.
- At least a portion of the surface of a polymer material used for the material for treating aneurysms of the present invention is modified by ion bombardment.
- Examples of the type of ion species implanted may include H + , He + , C + , N + , Ne + , Na + , N + , O + , Ar + , and Kr + .
- the type of ion species is not particularly limited to the above examples, unless it elutes to inhibit the growth of cells.
- a dose volume ⁇ is preferably 1 ⁇ 10 12 ⁇ 1 ⁇ 10 17 ions/cm 2 . If such a dose volume is lower than 1 ⁇ 10 12 ions/cm 2 , an effect of significantly improving cellular adhesiveness decreases. In contrast, if it is higher than 1 ⁇ 10 17 ions/cm 2 , the polymer material is easily disrupted. Thus, both cases are not favorable.
- Such a dose volume ⁇ is more preferably 1 ⁇ 10 13 ⁇ 1 ⁇ 10 16 ions/cm 2 .
- ion acceleration energy it is considered that an energy transmission mechanism differs depending on the longitudinal level of the energy.
- Such an acceleration energy is practically between 1 keV and 5 MeV.
- the lower limit of the acceleration energy can be set at 1 keV, 2 keV, 3 keV, 5 keV, 10 keV, 20 keV, 30 keV, 50 keV, or 100 keV, for example.
- the upper limit of the acceleration energy can be set at 5 MeV, 3 MeV, 2 MeV, or 1 MeV.
- the ion acceleration energy can be within the range of any given combination of the aforementioned lower and upper limits.
- a beam current density is preferably set at approximately 0.5 ⁇ A/cm 2 or less. This is because if such beam current density is excessive, the temperature of a polymer material as a target extremely increases, and thus the polymer material itself deteriorates and there is a risk that cellular adhesiveness decreases.
- An example of a means for giving ion bombardment in the present invention is ion implantation.
- the reaction itself is limited to an interaction between ion beam and a material to which ions are to be implanted (target material).
- target material a material to which ions are to be implanted
- ions can be embedded into any given depth from the surface.
- ion implantation has extremely good controllability. This is a characteristic, which a plasma treatment does not have.
- the implanted ions have a mechanism of exhibiting an electron stopping power against ions having a relatively light mass at the initial stage of diffusion, and exhibiting a nuclear stopping ability against ions having a relatively heavy mass from the beginning.
- the implanted ions bring on the heating of the polymer material due to lattice vibration (thermal non-equilibrium state), and cause fusion, amorphization, or the like.
- FIG. 2 shows the structural formula of ePTFE.
- An aseptically packed PSM-01200 was opened. After an ion beam had been irradiated thereto, it was sterilized with ethylene oxide gas (EOG) for animal experiments.
- EOG ethylene oxide gas
- An ion beam-irradiated sample was produced at an acceleration voltage of 150 keV in an amount irradiated of 5 ⁇ 10 14 Ar + ions/cm 2 and 1 ⁇ 10 14 Kr + ions/cm 2 , using an ion implanter, RIKEN 200 kV Low Current Implanter. Irradiation was carried out at an ion beam current of 0.05 ⁇ A/cm 2 .
- the unirradiated sample When an irradiated sample is compared with an unirradiated sample, the unirradiated sample has a higher density than that of the irradiated sample, and also has larger quantities of filamentous portions between nodes than in the case of the irradiated sample. This is because such bonds are cleaved by irradiation of ions.
- the Ar + -irradiated sample When an Ar + -irradiated sample is compared with a Kr + -irradiated sample, the Ar + -irradiated sample has greater damage.
- FIG. 4 shows FT-IR-ATR spectra. It was observed that the double bonds of —OH groups and carbon atoms were increased by ion implantation in the order of control, Kr, and Ar, and that CF 2 was decreased in the order of control, Kr, and Ar.
- CF 2 is decomposed by irradiation of an ion beam, and as a result, carbon-carbon double bonds are formed. Irradiation of an Ar + ion beam having a larger amount of decomposition causes a larger amount of functional groups generated.
- the samples were analyzed by the Raman microspectroscopy (LabRam manufactured by Joban Yvon). Measurement conditions consisted of a He—Ne laser of 632.817 nm and an accumulation number of 5-times/3 sec.
- FIG. 5 shows a Raman spectrum.
- PBS( ⁇ ) phosphate buffer
- L929 fibroblasts hardly adhere to an unirradiated ePTFE portion, but these cells selectively adhere to an ion beam irradiated portion. In addition, at an initial stage, the cells more significantly adhere to an Ar + ion beam-irradiated portion than to a Kr + ion beam irradiated portion.
- FIG. 7 shows the state of the sample after a rabbit carotid artery has been wrapped with the above sample.
- aneurysm models were produced from 5 mature beagle dogs (with a body weight of 10 kg). Thereafter, an experiment was carried out, wherein the sample was attached to the periphery of the aneurysm area only with the plasma derivative living tissue adhesive Bolheal.
- FIG. 8 shows an aneurysm model.
- FIG. 9 shows the state of a wrapped aneurysm of a beagle dog.
- the carotid artery of a rabbit which had been wrapped by the aforementioned method, was excised, and it was then fixed with formalin. Thereafter, it was stained with hematoxylin and eosin (HE) and was then observed with a phase contrast microscope. Thereafter, the material used for wrapping the rabbit carotid artery was subjected to a histological test.
- HE hematoxylin and eosin
- FIG. 10 shows a histological photograph of the sample used to wrap unirradiated ePTFE. (a) was observed at a magnification of 100-fold, and (b) was observed at a magnification of 400-fold. The unirradiated sample did not adhere to the vascular wall.
- FIG. 11 shows a histological photograph of 5 ⁇ 10 14 Ar + -irradiated material (1 week).
- the Ar + -irradiated material showed a good adhesion to the vascular wall.
- FIG. 12 shows a histological photograph of 1 ⁇ 10 14 Kr + -irradiated material (1 week) used to wrap a rabbit carotid artery. As in the case of the Ar + -irradiated sample, the Kr + -irradiated surface showed good adhesion to the vascular wall.
- FIG. 13 shows a histological photograph of 5 ⁇ 10 14 Ar + -irradiated material (1 month). It was observed that the vascular wall adhering to the irradiated surface had been repaired.
- FIG. 14 shows a histological photograph of 1 ⁇ 10 14 Kr + -irradiated material (1 month) used to wrap a rabbit carotid artery.
- the Kr + -irradiated surface showed a good adhesion to the vascular wall, and the repaired state was also good.
- the present invention provides a material having biocompatibility which is capable of treating aneurysms, and a production method thereof.
- the material for treating aneurysms of the present invention has both adhesiveness to the vascular wall and self-repairing ability, and it can effectively treat aneurysms.
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Polymerisation Methods In General (AREA)
Abstract
Description
- The present invention relates to a material for treating aneurysms, which can be used to treat aneurysms, and a production method thereof.
- Every year, subarachnoid hemorrhages caused by ruptured cerebral aneurysms occur to approximately 12 out of 100,000 people. More specifically, this malady occurs to approximately 15,000 people among a total population of 126,000,000 in Japan. Approximately 50% of such patients with subarachnoid hemorrhages die due to the first subarachnoid hemorrhage. Also, if a particular treatment is not given, 25% to 30% of such patients die due to rebleeding.
- As a therapeutic method for treating aneurysms, the clipping of an aneurysm neck portion by craniotomy (
FIG. 1 a), or a method of forming a thrombus in an aneurysm portion by an intravascular treatment using a detachable coil (FIG. 1 b), is adopted. Such methods are effective for a dome-shaped aneurysm, but in the treatment for a cerebral aneurysm having a risk of rupture called “wide neck aneurysm”, the clipping can not be carried out, and also the treatment using a coil can not be applied because the coil is moved to a peripheral portion due to the flowing of bloodstream. In order to prevent such a wide neck type aneurysm from rupture, the affected area is wrapped with ePTFE fiber, an ePTFE sheet or silk fiber, and thereafter a living tissue adhesive called a fibrin glue is used. However, these materials are extremely poor in terms of affinity with a vascular wall and the adhesiveness of a fibrin glue. Thus, the materials often become detached, and it becomes impossible to prevent such rupture by strong wrapping in the actual situation. Accordingly, clinicians have desired a material for quickly and strongly wrapping such a wide neck type cerebral aneurysm, which is capable of preventing the rupture thereof. - Moreover, it has been proposed that a polymer material modified by ion bombardment be used for various types of biomaterials. For example, a cell-adhesive material, which is composed of a polymer material containing carbon as a constitutional element and which is produced by modifying at least a portion of the surface thereof by ion bombardment (Japanese Patent Application Laid-Open (Kokai) No. 5-49689), and a material for adhering to bone and/or fascia, which is composed of a polymer material containing carbon as a constitutional element and which is produced by modifying at least a portion of the surface thereof by ion bombardment (Japanese Patent Application Laid-Open (Kokai) No. 2002-315821), have been reported. In addition to the aforementioned examples, further examples of surface modification by ion bombardment are described in, for example, Endothelial Cell Adhesion to Ion Implanted Polymers, Y. Suzuki, M. Kusakabe, J.-S. Lee, M. Kaibara, M. Iwaki, and H. Sasabe, Nucl. Instr. and Meth., B65, (1992) pp. 142-147; Application of Ion Beam to Polymer Materials and Application to Artificial Dura Mater, Y. Suzuki, Y. Murakami, A. Nakao, M. Iwaki, M. Kaihabara, and M. Kamio, Ionics-Science and Technology of Ions, Vol: 25, No. 284 (1999) pp. 47-54; Surface Modification of Polymer by Ion Beam Application, Y. Suzuki, M. Kusakabe, and M. Iwaki, Polymers, Vol. 41, No. 5, 338 (1992); Application of Ion Beam-Irradiated ePTFE to Artificial Dura Mater, Y. Suzuki, M. Iwaki, M. Kaibara, S. Tani, G. Ohashi, and M. Kamio, Ionics-Science and Technology of Ions, Vol: 27, No. 7 (2001) pp. 3-11; A New Surface Modification Technique of Platinum Coils by Ion Implantation and Protein Coating, Use in Intravascular Treatment of Brain Aneurysms, Y Murayama, Y Suzuki, F. Vinuela, T. F. Massoud, H. M. Do, G. Guglielmi, M. Iwaki, M. Kamio, and T. Abe, Nucl. Instr. and Meth. in Phys. Res. B127/128 (1997) pp. 1015-1018; Ion Implantation and Protein Coating of Detachable Coils for Endovascular Treatment of Cerebral Aneurysmas: Concepts and Preliminary Results in Swine Models, Y. Murayama, F. Vinuela, Y. Suzuki, H. M. Do, T. F. Massoud, G. Guglielmi, D. Ji, M. Iwaki, M. Kusakabe, M. Kamio, and T. Abe, Neurosurgery, Vol. 40, No. 6 (1997) pp. 1233-1244; Development of a Biologically Active Guglielmi Detachable Coil for the Treatment of Cerebral Aneurysms, Part I: In Vitro Study, Y. Murayama, Y. Suzuki, F. Vinuela, M. Kaibara, K. Kurotobi, M. Iwaki, and T. Abe, AJNR Am J Neuroradiol 20:1986-1991 (1999); and Development of a Biologically Active Guglielmi Detachable Coil for the Treatment of Cerebral Aneurysms, Part II: An Experimental Study in a Swine Aneurysm Model, Y. Murayama, F. Vinuela, Y. Suzuki, Y. Akiba, A. Ulihoa, G. Duckwiler, Y. Gobin, H. Vinters, M. Iwaki, and T. Abe., AJNR Am J Neuroradiol 20: 1992-1999 (1999), and the like.
- It is an object of the present invention to provide a polymer material, the histocompatibility of which has been improved by irradiation of ion beam, which prevents an aneurysm having a risk of rupture from actually rupturing.
- Ion beam-irradiated ePTFE has cellular adhesiveness. When this material is used as a wrapping material for preventing the rupture of an aneurysm, it exhibits affinity with the outer wall of the blood vessel and has a rupture-preventing effect. In addition, when the rupture of an aneurysm occurs in the wrapping, the above material has a property of preventing the leakage of blood in the brain, because of its strong fixing ability. Moreover, since the above material has cellular adhesiveness, the self-repairing ability of the vascular wall is also improved. The preset invention has been completed based on these findings.
- That is to say, the present invention provides a material for treating aneurysms, which is composed of a polymer material containing carbon as a constitutional element, and which is produced by modifying at least a portion of the surface thereof by ion bombardment.
- Preferably, the polymer material containing carbon as a constitutional element is expanded polytetrafluoroethylene (ePTFE), polylactic acid, silicone, or silk.
- Preferably, modification by ion bombardment is carried out by ion implantation using an ion beam with an acceleration energy that is between 1 keV and 2 MeV.
- Preferably, modification by ion bombardment is carried out by ion implantation within a dose volume φ such that 1×1012≦φ<1×1017 ions/cm2.
- In another aspect, the present invention provides a method for producing a material for treating aneurysms, which is characterized in that ions are implanted into at least a portion of the surface of a polymer material containing carbon as a constitutional element, within a dose volume φ such that 1×1012≦φ<1×1017 ions/cm2.
- Preferably, the polymer material containing carbon as a constitutional element is expanded polytetrafluoroethylene (ePTFE), polylactic acid, silicone, or silk.
- In another aspect, the present invention provides the use of a polymer material containing carbon as a constitutional material, at least a portion of the surface of which has been modified by ion bombardment, for the production of a material for treating aneurysms.
- In a further aspect, the present invention provides a method for treating aneurysms, which comprises wrapping the aneurysm of a patient using a polymer material containing carbon as a constitutional material, at least a portion of the surface of which has been modified by ion bombardment.
-
FIG. 1 shows the summary of a method for treating aneurysms.FIG. 1 a shows the clipping of an aneurysm neck portion;FIG. 1 b shows a therapeutic method involving the formation of a thrombus; andFIG. 1 c shows wrapping (whereby the periphery of an aneurysm is wrapped with ePTFE). -
FIG. 2 shows the structural formula of ePTFE. -
FIG. 3 shows SEM images (×8,000) of: (a) unirradiated ePTFE; (b) 5×1014 Ar+-irradiated sample; and (c) 1×1014 Kr+-irradiated sample. -
FIG. 4 shows the FT-IR-ATR spectra of (a) unirradiated ePTFE; (b) 5×1014 Ar+-irradiated sample; and (c) 1×1014 Kr+-irradiated sample. -
FIG. 5 shows the Raman spectrum of ePTFE sample. -
FIG. 6 shows images of cultured cells observed with a phase contract microscope: - (a) Ar+, 5×1014, on the first day;
- (b) Kr+, 1×1014, on the first day;
- (c) Ar+, 5×1014, on the second day; and
- (d) Kr+, 1×1014, on the second day.
-
FIG. 7 shows the state of the sample of the present invention after a rabbit carotid artery has been wrapped with the above sample. -
FIG. 8 shows an aneurysm model produced in the carotid artery of a beagle dog. -
FIG. 9 shows the state of a wrapped aneurysm of a beagle dog. -
FIG. 10 shows a histological photograph of unirradiated ePTFE (3 months) used to wrap a rabbit carotid artery. (a) indicates 100-fold, and (b) indicates 400-fold. -
FIG. 11 shows a histological photograph of Ar+-irradiated ePTFE (1 week) used to wrap a rabbit carotid artery. (a) indicates 100-fold, and (b) indicates 400-fold. -
FIG. 12 shows a histological photograph of Kr+-irradiated material (1 week) used to wrap a rabbit carotid artery. (a) indicates 100-fold, and (b) indicates 400-fold. -
FIG. 13 shows a histological photograph of Ar+-irradiated ePTFE (1 month) used to wrap a rabbit carotid artery. (a) indicates 100-fold, and (b) indicates 400-fold. -
FIG. 14 shows a histological photograph of Kr+-irradiated material (1 month) used to wrap a rabbit carotid artery. (a) indicates 100-fold, and (b) indicates 400-fold. - The embodiments of the present invention will be described in detail below.
- As stated above, as a therapeutic method of a wide neck type cerebral aneurysm, only a method comprising wrapping the entire aneurysm with a polymer material and then adhering it with a blood-derived adhesive called a fibrin glue, so as to prevent the rupture of the aneurysm, has been applied. At present, a material such as ePTFE or silk has been used. However, such a material has poor cellular adhesiveness, and has no affinity with the outer wall of the blood vessel. In addition, the fixing ability of the fibrin glue is considerably weak in the actual situation.
- An ion beam-irradiated polymer material such as ePTFE has cellular adhesiveness, and also has affinity with the wrapped outer wall of the blood vessel. Even when the rupture of an aneurysm has occurred in the inside of the wrapping, since the above material has strong fixing ability, it is able to prevent the blood from leaking into the brain. Moreover, since the above material has cellular adhesiveness, the self-repairing ability of the vascular wall is also improved. Furthermore, as a result of in vitro experiments and animal experiments, it became clear that the adhesiveness of a fibrin glue is significantly improved by irradiation of ion beam. The use of this material enables a more complete treatment of an unruptured aneurysm. That is to say, the present invention relates to a material for treating aneurysms, which is formed by irradiation of ion beam to a polymer material (for example, expanded polytetrafluoroethylene, polylactic acid, silicone, silk, etc.), so as to impart cellular adhesiveness thereto.
- The type of a polymer material containing carbon as a constitutional element used in the present invention is not particularly limited, as long as it is a material having biocompatibility and good handlability, and any given material can be used. Examples of a polymer material preferably used in the present invention may include expanded polytetrafluoroethylene (ePTFE), polylactic acid, silicone, and silk. Of these, expanded polytetrafluoroethylene (ePTFE) is particularly preferable.
- At least a portion of the surface of a polymer material used for the material for treating aneurysms of the present invention is modified by ion bombardment. Examples of the type of ion species implanted may include H+, He+, C+, N+, Ne+, Na+, N+, O+, Ar+, and Kr+. However, the type of ion species is not particularly limited to the above examples, unless it elutes to inhibit the growth of cells.
- A dose volume φ is preferably 1×1012≦φ<1×1017 ions/cm2. If such a dose volume is lower than 1×1012 ions/cm2, an effect of significantly improving cellular adhesiveness decreases. In contrast, if it is higher than 1×1017 ions/cm2, the polymer material is easily disrupted. Thus, both cases are not favorable. Such a dose volume φ is more preferably 1×1013≦φ<1×1016 ions/cm2.
- With regard to ion acceleration energy, it is considered that an energy transmission mechanism differs depending on the longitudinal level of the energy. Such an acceleration energy is practically between 1 keV and 5 MeV. For example, it is between 1 keV and 3 MeV. The lower limit of the acceleration energy can be set at 1 keV, 2 keV, 3 keV, 5 keV, 10 keV, 20 keV, 30 keV, 50 keV, or 100 keV, for example. On the other hand, the upper limit of the acceleration energy can be set at 5 MeV, 3 MeV, 2 MeV, or 1 MeV. Thus, the ion acceleration energy can be within the range of any given combination of the aforementioned lower and upper limits.
- A beam current density is preferably set at approximately 0.5 μA/cm2 or less. This is because if such beam current density is excessive, the temperature of a polymer material as a target extremely increases, and thus the polymer material itself deteriorates and there is a risk that cellular adhesiveness decreases.
- An example of a means for giving ion bombardment in the present invention is ion implantation. In the case of ion implantation, the reaction itself is limited to an interaction between ion beam and a material to which ions are to be implanted (target material). In addition, by selecting an ion incident energy, ions can be embedded into any given depth from the surface. Thus, ion implantation has extremely good controllability. This is a characteristic, which a plasma treatment does not have. The implanted ions have a mechanism of exhibiting an electron stopping power against ions having a relatively light mass at the initial stage of diffusion, and exhibiting a nuclear stopping ability against ions having a relatively heavy mass from the beginning. Anyway, the implanted ions bring on the heating of the polymer material due to lattice vibration (thermal non-equilibrium state), and cause fusion, amorphization, or the like.
- The present invention will be more specifically described in the following examples. However, these examples are not intended to limit the scope of the present invention.
- In the present example, Gore-Tex ePTFE patch II/pericardial sheet (PSM-01200) with a thickness of 0.1 mm (manufactured by Gore-Tex) was used.
FIG. 2 shows the structural formula of ePTFE. An aseptically packed PSM-01200 was opened. After an ion beam had been irradiated thereto, it was sterilized with ethylene oxide gas (EOG) for animal experiments. - An ion beam-irradiated sample was produced at an acceleration voltage of 150 keV in an amount irradiated of 5×1014 Ar+ ions/cm2 and 1×1014 Kr+ ions/cm2, using an ion implanter, RIKEN 200 kV Low Current Implanter. Irradiation was carried out at an ion beam current of 0.05 μA/cm2.
- (1) Observation of Surface Form with Field Emission Scanning Electron Microscope (FE-SEM, Manufactured by Jeol, JSM6330F)
- SEM images (×8,000) of (a) unirradiated ePTFE, (b) 5×1014 Ar+ ions/cm2 irradiated sample, and (c) 1×1014 Kr+ ions/cm2 irradiated sample, are shown in
FIG. 3 . - When an irradiated sample is compared with an unirradiated sample, the unirradiated sample has a higher density than that of the irradiated sample, and also has larger quantities of filamentous portions between nodes than in the case of the irradiated sample. This is because such bonds are cleaved by irradiation of ions. When an Ar+-irradiated sample is compared with a Kr+-irradiated sample, the Ar+-irradiated sample has greater damage.
- (2) Measurement by Attenuated Total Reflectance Fourier Transform Infrared Spectrophotometry (FT-IR-ATR Method)
- Functional groups generated by ion implantation and bond cleavage were measured by the attenuated total reflectance Fourier transform infrared spectrophotometry (Nexsus 470 manufactured by Nicolet). The measurement was carried out under conditions of an internal element of Ge 45°, a resolution of cm−1, and an accumulation number of 200.
-
FIG. 4 shows FT-IR-ATR spectra. It was observed that the double bonds of —OH groups and carbon atoms were increased by ion implantation in the order of control, Kr, and Ar, and that CF2 was decreased in the order of control, Kr, and Ar. - Based on the relationship between the amount of functional groups generated and the amount of CF2 decomposed, CF2 is decomposed by irradiation of an ion beam, and as a result, carbon-carbon double bonds are formed. Irradiation of an Ar+ ion beam having a larger amount of decomposition causes a larger amount of functional groups generated.
- (3) Measurement by Raman Microspectroscopy
- The samples were analyzed by the Raman microspectroscopy (LabRam manufactured by Joban Yvon). Measurement conditions consisted of a He—Ne laser of 632.817 nm and an accumulation number of 5-times/3 sec.
FIG. 5 shows a Raman spectrum. - It was observed that CF2 was decreased in the order of control, Kr, and Ar, and that carbon-carbon double bonds were increased in the order of control, Kr, and Ar.
- (4) Experiment Regarding Cellular Adhesiveness
- A sample, which had been patterned to a round shape of approximately 100 microns by irradiation, was sterilized with ultraviolet ray. Thereafter, the resultant sample was placed in a Petri dish with a diameter of 60 mm, and 5 ml of a suspension of L929 (2.5×104 cells/ml) was then added dropwise thereto. The obtained mixture was cultured for several days in an incubator at 37° C. in the presence of 5% CO2. After completion of the culture, the obtained culture product was washed with a phosphate buffer (PBS(−)) twice, and the resultant product was then fixed with 2% glutaraldehyde in a refrigerator for 1 hour. Thereafter, the obtained product was dehydrated in 50%, 70%, 90%, and 100% ethanol ascending series. ePTFE, which became transparent as a result of immersion in 100% ethanol, was observed with a phase contrast microscope at a magnification of 100-fold. Images of cultured cells observed with a phase contract microscope are shown in
FIG. 6 . - L929 fibroblasts hardly adhere to an unirradiated ePTFE portion, but these cells selectively adhere to an ion beam irradiated portion. In addition, at an initial stage, the cells more significantly adhere to an Ar+ ion beam-irradiated portion than to a Kr+ ion beam irradiated portion.
- For in vivo (in living bodies) evaluation, 13 Japanese white rabbits (with a body weight between 3 and 4.5 kg) were subjected to the experiment. Two types of samples were produced by irradiating 5×1014 Ar++ or 1×1014 Kr+ at an acceleration energy of 150 keV to the entire surface of Gore-Tex ePTFE patch II/pericardial sheet (PSM-01200) with a thickness of 0.1 mm manufactured by Gore-Tex. The carotid artery of each of the above rabbits was wrapped with such two types of samples. The upstream side of the blood vessel was just wrapped. In order to observe self-repairing ability, the downstream side thereof was wrapped such that the ion-irradiated surface was allowed to come into contact with the blood vessel, after the outer membrane had been eliminated. Thereafter, the downstream side was fixed with a plasma derivative living tissue adhesive Bolheal (manufactured by Kaketsuken, the Chemo-Sero-Therapeutic Research Institute), and it was then clipped. The experiment was carried out for an acute case (1 week) and chronic cases (1 month, 3 months).
FIG. 7 shows the state of the sample after a rabbit carotid artery has been wrapped with the above sample. - Moreover, aneurysm models were produced from 5 mature beagle dogs (with a body weight of 10 kg). Thereafter, an experiment was carried out, wherein the sample was attached to the periphery of the aneurysm area only with the plasma derivative living tissue adhesive Bolheal.
FIG. 8 shows an aneurysm model.FIG. 9 shows the state of a wrapped aneurysm of a beagle dog. - The carotid artery of a rabbit, which had been wrapped by the aforementioned method, was excised, and it was then fixed with formalin. Thereafter, it was stained with hematoxylin and eosin (HE) and was then observed with a phase contrast microscope. Thereafter, the material used for wrapping the rabbit carotid artery was subjected to a histological test.
-
FIG. 10 shows a histological photograph of the sample used to wrap unirradiated ePTFE. (a) was observed at a magnification of 100-fold, and (b) was observed at a magnification of 400-fold. The unirradiated sample did not adhere to the vascular wall. -
FIG. 11 shows a histological photograph of 5×1014 Ar+-irradiated material (1 week). The Ar+-irradiated material showed a good adhesion to the vascular wall. -
FIG. 12 shows a histological photograph of 1×1014 Kr+-irradiated material (1 week) used to wrap a rabbit carotid artery. As in the case of the Ar+-irradiated sample, the Kr+-irradiated surface showed good adhesion to the vascular wall. -
FIG. 13 shows a histological photograph of 5×1014 Ar+-irradiated material (1 month). It was observed that the vascular wall adhering to the irradiated surface had been repaired. -
FIG. 14 shows a histological photograph of 1×1014 Kr+-irradiated material (1 month) used to wrap a rabbit carotid artery. As in the case of the Ar+-irradiated sample, the Kr+-irradiated surface showed a good adhesion to the vascular wall, and the repaired state was also good. - From the results shown in these histological photographs, it became clear that the unirradiated ePTFE portion does not have adhesiveness to the vascular wall, but that the ion beam-irradiated portion has such adhesiveness. When the affected area is wrapped with ion beam-irradiated ePTFE, self-repairing ability was observed in a portion, from which the outer membrane had been eliminated. From these results, it is found that, by wrapping the outer wall of an aneurysm having a risk of rupture with the present material, a sufficient effect of preventing the rupture can be achieved.
- The present invention provides a material having biocompatibility which is capable of treating aneurysms, and a production method thereof. The material for treating aneurysms of the present invention has both adhesiveness to the vascular wall and self-repairing ability, and it can effectively treat aneurysms.
Claims (10)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003-207850 | 2003-08-19 | ||
JP2003207850A JP2007020590A (en) | 2003-08-19 | 2003-08-19 | Material for aneurysm curing |
PCT/JP2004/012138 WO2005016324A1 (en) | 2003-08-19 | 2004-08-18 | Material for aneurysm curing |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/012138 A-371-Of-International WO2005016324A1 (en) | 2003-08-19 | 2004-08-18 | Material for aneurysm curing |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/024,718 Division US8268300B2 (en) | 2003-08-19 | 2011-02-10 | Material for aneurysm curing |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070185570A1 true US20070185570A1 (en) | 2007-08-09 |
Family
ID=34190078
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/568,694 Abandoned US20070185570A1 (en) | 2003-08-19 | 2004-08-18 | Material for aneurysm curing |
US13/024,718 Expired - Fee Related US8268300B2 (en) | 2003-08-19 | 2011-02-10 | Material for aneurysm curing |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/024,718 Expired - Fee Related US8268300B2 (en) | 2003-08-19 | 2011-02-10 | Material for aneurysm curing |
Country Status (4)
Country | Link |
---|---|
US (2) | US20070185570A1 (en) |
EP (1) | EP1656932B1 (en) |
JP (1) | JP2007020590A (en) |
WO (1) | WO2005016324A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110070411A1 (en) * | 2009-09-23 | 2011-03-24 | Hyundai Motor Company | Plastic with improved gloss properties and surface treatment method |
US20110076460A1 (en) * | 2009-09-28 | 2011-03-31 | Hyundai Motor Company | Plastic with nano-embossing pattern and method for preparing the same |
US20110196415A1 (en) * | 2003-08-19 | 2011-08-11 | Riken | Material for aneurysm curing |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080026329A1 (en) * | 2006-07-26 | 2008-01-31 | Ashkan Vaziri | Surface modification of polymer surface using ion beam irradiation |
WO2009132045A2 (en) | 2008-04-21 | 2009-10-29 | Nfocus Neuromedical, Inc. | Braid-ball embolic devices and delivery systems |
US9675482B2 (en) | 2008-05-13 | 2017-06-13 | Covidien Lp | Braid implant delivery systems |
CA2731735A1 (en) | 2008-07-22 | 2010-01-28 | Microtherapeutics, Inc. | Vascular remodeling device |
ES2534192T3 (en) | 2009-11-09 | 2015-04-20 | Covidien Lp | Features of mesh ball embolic device |
CN102770091B (en) | 2010-01-28 | 2015-07-08 | 泰科保健集团有限合伙公司 | Vascular remodeling device |
US9468442B2 (en) | 2010-01-28 | 2016-10-18 | Covidien Lp | Vascular remodeling device |
CN103442653B (en) | 2011-02-11 | 2016-06-01 | 柯惠有限合伙公司 | Two benches launches aneurysma embolization device |
WO2012134990A1 (en) | 2011-03-25 | 2012-10-04 | Tyco Healthcare Group Lp | Vascular remodeling device |
WO2013049448A1 (en) | 2011-09-29 | 2013-04-04 | Covidien Lp | Vascular remodeling device |
US9314248B2 (en) | 2012-11-06 | 2016-04-19 | Covidien Lp | Multi-pivot thrombectomy device |
WO2014078458A2 (en) | 2012-11-13 | 2014-05-22 | Covidien Lp | Occlusive devices |
US9295571B2 (en) | 2013-01-17 | 2016-03-29 | Covidien Lp | Methods and apparatus for luminal stenting |
US9463105B2 (en) | 2013-03-14 | 2016-10-11 | Covidien Lp | Methods and apparatus for luminal stenting |
EP2967571B1 (en) | 2013-03-15 | 2022-08-31 | Covidien LP | Occlusive device |
JP6533908B2 (en) * | 2014-01-06 | 2019-06-26 | 公立大学法人首都大学東京 | Method of manufacturing molded body |
US10478194B2 (en) | 2015-09-23 | 2019-11-19 | Covidien Lp | Occlusive devices |
JP6263305B1 (en) * | 2017-08-01 | 2018-01-17 | 株式会社多磨バイオ | Medical sheet |
JP6426812B1 (en) * | 2017-08-01 | 2018-11-21 | 株式会社多磨バイオ | Medical seat |
EP4054440B1 (en) | 2019-11-04 | 2024-06-05 | Covidien LP | Manufacturing method of devices for treatment of intracranial aneurysms |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5152783A (en) * | 1989-09-28 | 1992-10-06 | Sony Corporation | Antithrombogenic material |
US5308704A (en) * | 1991-08-20 | 1994-05-03 | Sony Corporation | Cell adhesive material and method for producing same |
US5891192A (en) * | 1997-05-22 | 1999-04-06 | The Regents Of The University Of California | Ion-implanted protein-coated intralumenal implants |
US20020155295A1 (en) * | 2001-04-23 | 2002-10-24 | Riken | Artificial dura mater having cell adhesiveness and a process for producing the same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3112560B2 (en) | 1992-05-08 | 2000-11-27 | 日本金属株式会社 | High frequency welding equipment |
JP4445697B2 (en) * | 2002-08-30 | 2010-04-07 | 独立行政法人理化学研究所 | Biological repair material having affinity with biological tissue adhesive |
JP2007020590A (en) | 2003-08-19 | 2007-02-01 | Institute Of Physical & Chemical Research | Material for aneurysm curing |
-
2003
- 2003-08-19 JP JP2003207850A patent/JP2007020590A/en active Pending
-
2004
- 2004-08-18 WO PCT/JP2004/012138 patent/WO2005016324A1/en not_active Application Discontinuation
- 2004-08-18 US US10/568,694 patent/US20070185570A1/en not_active Abandoned
- 2004-08-18 EP EP20040772099 patent/EP1656932B1/en not_active Not-in-force
-
2011
- 2011-02-10 US US13/024,718 patent/US8268300B2/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5152783A (en) * | 1989-09-28 | 1992-10-06 | Sony Corporation | Antithrombogenic material |
US5308704A (en) * | 1991-08-20 | 1994-05-03 | Sony Corporation | Cell adhesive material and method for producing same |
US5891192A (en) * | 1997-05-22 | 1999-04-06 | The Regents Of The University Of California | Ion-implanted protein-coated intralumenal implants |
US20020155295A1 (en) * | 2001-04-23 | 2002-10-24 | Riken | Artificial dura mater having cell adhesiveness and a process for producing the same |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110196415A1 (en) * | 2003-08-19 | 2011-08-11 | Riken | Material for aneurysm curing |
US8268300B2 (en) | 2003-08-19 | 2012-09-18 | Riken | Material for aneurysm curing |
US20110070411A1 (en) * | 2009-09-23 | 2011-03-24 | Hyundai Motor Company | Plastic with improved gloss properties and surface treatment method |
US20110076460A1 (en) * | 2009-09-28 | 2011-03-31 | Hyundai Motor Company | Plastic with nano-embossing pattern and method for preparing the same |
Also Published As
Publication number | Publication date |
---|---|
EP1656932A1 (en) | 2006-05-17 |
US20110196415A1 (en) | 2011-08-11 |
EP1656932A4 (en) | 2009-09-02 |
JP2007020590A (en) | 2007-02-01 |
US8268300B2 (en) | 2012-09-18 |
WO2005016324A1 (en) | 2005-02-24 |
EP1656932B1 (en) | 2013-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8268300B2 (en) | Material for aneurysm curing | |
Hardy et al. | Responsive biomaterials: advances in materials based on shape‐memory polymers | |
CA2173546C (en) | Medical materials and manufacturing methods thereof | |
US5891192A (en) | Ion-implanted protein-coated intralumenal implants | |
Yoshimoto et al. | Development of layered PLGA membranes for periodontal tissue regeneration | |
JP5538217B2 (en) | Cell-free tissue matrix construct for tissue repair | |
WO1999044538A1 (en) | Biodegradable polymer/protein based coils for intralumenal implants | |
Riau et al. | Surface modification of PMMA to improve adhesion to corneal substitutes in a synthetic core–skirt keratoprosthesis | |
JP2009542348A (en) | Implantable medical article with pre-healing coating | |
US20110276124A1 (en) | Biocorrodable implant in which corrosion may be triggered or accelerated after implantation by means of an external stimulus | |
MX2008006463A (en) | Nerve guide. | |
JP2009153947A (en) | Nerve regeneration inducing tube | |
Riau et al. | Surface modifications of the PMMA optic of a keratoprosthesis to improve biointegration | |
Ackermann et al. | Collagen‐inducing biologization of prosthetic material for hernia repair: Polypropylene meshes coated with polyP/collagen | |
Suzuki | Ion beam modification of polymers for the application of medical devices | |
WO2011007152A1 (en) | Polymeric collagen biomaterials | |
Vrana et al. | Modification of macroporous titanium tracheal implants with biodegradable structures: Tracking in vivo integration for determination of optimal in situ epithelialization conditions | |
Jansen et al. | Epithelial reaction to percutaneous implant materials: in vitro and in vivo experiments | |
JP2002143290A (en) | Crosslinking composite biomaterial | |
JP6529090B2 (en) | in situ tissue engineering | |
JP2002315821A (en) | Artificial dura mater having cell adhesiveness and method for making the same | |
KR101593455B1 (en) | Method for Surface treatment of materials for artificial vessel | |
KR100700674B1 (en) | Collagen conduit coated with synthetic biodegradable polymer and method for the production thereof | |
Li et al. | Chitosan conduit for peripheral nerve regeneration | |
JPWO2007007452A1 (en) | Artificial blood vessel and manufacturing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE, THE, JA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:UJIIE, HIROSHI;SUZUKI, YOSHIAKI;IWAKI, MASAYA;AND OTHERS;REEL/FRAME:018321/0460 Effective date: 20060831 Owner name: RIKEN, JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:UJIIE, HIROSHI;SUZUKI, YOSHIAKI;IWAKI, MASAYA;AND OTHERS;REEL/FRAME:018321/0460 Effective date: 20060831 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE, JAP Free format text: CHANGE OF ASSIGNEE ADDRESS;ASSIGNOR:THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE;REEL/FRAME:028450/0480 Effective date: 20060831 |